Home › Trial NCT03810976
A Study of Eribulin With Gemcitabine in Patients With Advanced Liposarcoma or Leiomyosarcoma
- Trial IDNCT03810976
- StatusCompleted
- PhasePhase 2
- Study typeInterventional
- SponsorYonsei University
- Enrollment37
- Start date2018-03-27
- ConditionsSarcoma
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.